St. Jude Medical Inc. has finally secured an FDA advisory panel date for its Amplatzer patent foreman ovale occluder. The firm's PMA for the implant, intended to prevent recurrent stroke, will go before the agency's Circulatory System Devices panel May 24.
It has been a challenging path so far for the PFO closure device. St. Jude's 980-patient pivotal RESPECT trial missed...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?